IRON
Disc Medicine Inc.
NASDAQ: IRON · HEALTHCARE · BIOTECHNOLOGY
$65.97
-1.92% today
Updated 2026-04-29
Market cap
$2.52B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.01
Dividend yield
—
52W range
$40 – $100
Volume
0.5M
Disc Medicine Inc. (IRON) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — |
| Cost of revenue | $322000.00 | $192000.00 | $300000.00 | $100000.00 | $156000.00 | $281000.00 |
| Gross profit | $-322000.00 | $-192000.00 | $-300000.00 | $-100000.00 | $-156000.00 | $-281000.00 |
| Gross margin | — | — | — | — | — | — |
| R&D | $28.17M | $25.17M | $33.44M | $69.26M | $96.67M | $170.64M |
| SG&A | $5.87M | $5.76M | $14.04M | $21.86M | $33.05M | $65.38M |
| Operating income | $-34.04M | $-30.93M | $-47.48M | $-91.13M | $-129.72M | $-236.02M |
| Operating margin | — | — | — | — | — | — |
| EBITDA | $-33.69M | $-30.90M | $-47.39M | $-76.23M | $-108.27M | $-207.94M |
| EBITDA margin | — | — | — | — | — | — |
| EBIT | $-34.01M | $-30.93M | $-47.48M | $-76.33M | $-108.43M | $-208.22M |
| Interest expense | $6.83M | $2.16M | $737000.00 | $0.00 | $572000.00 | $3.61M |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-40.84M | $-35.97M | $-46.09M | $-76.43M | $-109.36M | $-212.18M |
| Net income growth (YoY) | — | +11.9% | -28.1% | -65.8% | -43.1% | -94.0% |
| Profit margin | — | — | — | — | — | — |